101 related articles for article (PubMed ID: 10078962)
1. Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.
Visse E; Siesjö P; Widegren B; Sjögren HO
Cancer Gene Ther; 1999; 6(1):37-44. PubMed ID: 10078962
[TBL] [Abstract][Full Text] [Related]
2. Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.
Siesjö P; Visse E; Sjögren HO
J Immunother Emphasis Tumor Immunol; 1996 Sep; 19(5):334-45. PubMed ID: 8941873
[TBL] [Abstract][Full Text] [Related]
3. Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts.
Siesjö P; Visse E; Lindvall M; Salford L; Sjögren HO
Cancer Immunol Immunother; 1993 Jul; 37(1):67-74. PubMed ID: 8513454
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of glioma-infiltrating leucocytes after peripheral therapeutic immunization with interferon-gamma-transfected glioma cells.
Visse E; Johansson AC; Widegren B; Sjögren HO; Siesjö P
Cancer Immunol Immunother; 2000 Jun; 49(3):142-51. PubMed ID: 10881693
[TBL] [Abstract][Full Text] [Related]
5. Radiation immunomodulatory gene tumor therapy of rats with intracerebral glioma tumors.
Persson BR; Koch CB; Grafström G; Ceberg C; Munckaf Rosenschöld P; Nittby H; Widegren B; Salford LG
Radiat Res; 2010 Apr; 173(4):433-40. PubMed ID: 20334515
[TBL] [Abstract][Full Text] [Related]
6. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines.
Cayeux S; Beck C; Aicher A; Dörken B; Blankenstein T
Eur J Immunol; 1995 Aug; 25(8):2325-31. PubMed ID: 7545119
[TBL] [Abstract][Full Text] [Related]
7. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
[TBL] [Abstract][Full Text] [Related]
8. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer to liver cancer cells of B7-1 plus interleukin 12 changes immunoeffector mechanisms and suppresses helper T cell type 1 cytokine production induced by interleukin 12 alone.
Sun Y; Qian C; Peng D; Prieto J
Hum Gene Ther; 2000 Jan; 11(1):127-38. PubMed ID: 10646645
[TBL] [Abstract][Full Text] [Related]
10. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
11. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
Tjuvajev J; Gansbacher B; Desai R; Beattie B; Kaplitt M; Matei C; Koutcher J; Gilboa E; Blasberg R
Cancer Res; 1995 May; 55(9):1902-10. PubMed ID: 7728757
[TBL] [Abstract][Full Text] [Related]
12. B7-1, IFN gamma and anti-CTLA-4 co-operate to prevent T-cell tolerization during immunotherapy against a murine T-lymphoma.
Van Ginderachter JA; Liu Y; Geldhof AB; Brijs L; Thielemans K; De Baetselier P; Raes G
Int J Cancer; 2000 Aug; 87(4):539-47. PubMed ID: 10918195
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.
Badn W; Hegardt P; Fellert MA; Darabi A; Esbjörnsson M; Smith KE; Janelidze S; Salford LG; Visse E; Siesjö P
Scand J Immunol; 2007 Mar; 65(3):289-97. PubMed ID: 17309784
[TBL] [Abstract][Full Text] [Related]
14. [Effect of bone marrow stromal cells transfected with interleukin 18 on growth of intracranial glioma in rats].
Li CH; Jiao BH
Ai Zheng; 2007 Jan; 26(1):38-43. PubMed ID: 17222365
[TBL] [Abstract][Full Text] [Related]
15. Tumor cells cotransduced with B7.1 and gamma-IFN induce effective rejection of established parental tumor.
Yang S; Vervaert CE; Seigler HF; Darrow TL
Gene Ther; 1999 Feb; 6(2):253-62. PubMed ID: 10435110
[TBL] [Abstract][Full Text] [Related]
16. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
Janelidze S; Bexell D; Badn W; Darabi A; Smith KE; Fritzell S; Gunnarsson S; Milos P; Bengzon J; Salford LG; Siesjö P; Visse E
J Immunother; 2009; 32(6):593-601. PubMed ID: 19483650
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats.
Xu G; Guo Y; Seng Z; Cui G; Qu J
Oncol Rep; 2015 Oct; 34(4):1915-22. PubMed ID: 26252165
[TBL] [Abstract][Full Text] [Related]
18. B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.
Paul DB; Barth RF; Yang W; Shen GH; Kim J; Triozzi PL
Gene Ther; 2000 Jun; 7(12):993-9. PubMed ID: 10871746
[TBL] [Abstract][Full Text] [Related]
19. Induction and maintenance of T-cell response to a nonimmunogenic murine mesothelioma cell line requires expression of B7-1 and the capacity to upregulate class II major histocompatibility complex expression.
Leong C; Marley J; Loh S; Robinson B; Garlepp M
Cancer Gene Ther; 1996; 3(5):321-30. PubMed ID: 8894251
[TBL] [Abstract][Full Text] [Related]
20. Treatment of intracerebral glioblastomas with G422 tumour cell vaccine in a mouse model.
Ma YH; Yu JB; Yao HP; Zhan RY; Zheng JS
J Int Med Res; 2008; 36(2):308-13. PubMed ID: 18380941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
